Prot# SG040-0005: A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy (Rituximab, Ifosfamide, Carboplatin, and Etoposide) With and Without SGN-40 (anti-CD40 Humanized Monoclonal Antibody) for Second-Line Treatment of Patients with Diffus

Project: Research project

Project Details

StatusFinished
Effective start/end date12/1/07 → 12/1/10

Funding

  • PPD Development (SG040-0005 // SG040-0005)
  • Seattle Genetics, Inc. (SG040-0005 // SG040-0005)